澳洋健康(002172.SZ):擬出售與差別化粘膠短纖和普通粘膠纖維製造和銷售業務相關的資產
格隆匯 5 月 6日丨澳洋健康(002172.SZ)公佈,公司擬出售與差別化粘膠短纖和普通粘膠纖維製造和銷售業務相關的全部資產獲取現金。
標的資產即與差別化粘膠短纖和普通粘膠纖維製造和銷售業務相關的全部資產的交易對價為17.4億元。此次重大資產出售的交易價格系由交易雙方在公平、自願的原則下經過充分商業談判最終確定。
上市公司主營業務包括化學纖維、醫療健康兩大核心業務。化學纖維業務主要為粘膠短纖的生產銷售,最終銷售產品為粘膠短纖及高白、阻燃等差變化品種,屬於紡織原料。醫療健康業務主要包括醫療服務和醫藥物流業務。在醫療領域,公司形成了以澳洋醫院為總院,楊舍、三興等醫院為分院,核心優勢突出、輻射功能強大,立足基本醫療、兼具專科特色,總牀位超2100張的大型醫院集團;在醫藥物流領域,公司形成覆蓋華東、面向全國,全鏈盈利的大型現代化醫藥配送企業及跨區域醫藥零售連鎖企業。
此次交易的標的資產為與差別化粘膠短纖和普通粘膠纖維製造和銷售業務相關的全部資產。
通過此次交易,上市公司將實現公司的業務戰略調整,剝離化學纖維業務,全力投入醫療健康業務,實現業務轉型和產業升級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.